MARKET

VRXAW

VRXAW

Veraxa Biotech AG
NASDAQ
0.1210
0.00
0.00%
Opening 09:30 07/17 EDT
OPEN
--
PREV CLOSE
0.1210
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
0.3500
52 WEEK LOW
0.0501
MARKET CAP
--
P/E (TTM)
0.5649
1D
5D
1M
3M
1Y
5Y
1D
Why VERAXA Biotech (NASDAQ: VRXA) Could Benefit More Than Others From AI’s Growing Impact on Drug R&D 
TipRanks · 1d ago
VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development
TipRanks · 3d ago
Veraxa Biotech announces BiTAC pipeline collaboration with Ardigen
TipRanks · 4d ago
VERAXA Biotech Partners With AI-Driven Computational R&D Partner Ardigen To Support Its Growing BiTAC Pipeline Of T Cell Engagers And Antibody Drug Conjugates
Benzinga · 4d ago
Veraxa Biotech partners with Ardigen on AI-enabled drug discovery for BiTAC pipeline
PUBT · 4d ago
VERAXA BIOTECH TO LAUNCH AI-ENABLED DRUG DISCOVERY COLLABORATION WITH ARDIGEN TO SUPPORT GROWING BITAC® PIPELINE
Reuters · 4d ago
Weekly Report: what happened at VRXA last week (0706-0710)?
Weekly Report · 4d ago
FB Financial, Smith Micro Software And 3 Stocks To Watch Heading Into Monday
Benzinga · 4d ago
More

Webull offers Veraxa Biotech AG stock information, including NASDAQ: VRXAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRXAW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRXAW stock methods without spending real money on the virtual paper trading platform.